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Abstract Prostaglandins (PGs) have an important physiologi-
cal role in the modulation of various cell immune functions. The 
main sources of PGs during immune responses are monocyte 
cells. We report here the ability of non-stimulated macrophages 
to synthesize prostanoids and show that peritoneal mouse 
macrophages synthesize PGE2, PGF2a and thromboxane B2, 
spleen macrophages produce PGE2 and PGF2a, and in a fresh 
medium this synthesis reaches a constant basal level in a few 
hours. We studied the kinetics of Con A-induced proliferation of 
murine splenocytes under the influence of a wide range of PGE2 
concentrations (10 14-10 7 M). The suppressive effect of PGE2 
decreased when its concentration was lowered and disappeared at 
10~9 M PGE2 (this concentration corresponded to the basal level 
of non-stimulated macrophage synthesis of PGE2). Further 
lowering of the concentration became essential for the prolifera-
tion process once again, and at picomolar concentrations PGE2 
caused a suppressive effect comparable with that for 10 8 M 
PGE2. We also found that PGE2 significantly inhibited cell 
proliferation when it was added 1 h before the addition of 
mitogen, as compared with simultaneous mitogen addition. The 
effect was obtained for both low (10 12 M) and high (10 8 M) 
PGE2 concentrations. This phenomenon of PGE2 biphasic 
control of lymphocyte proliferation may play an important role 
in cellular homeostasis, in particular in immune cell function 
regulation. 
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1. Introduction 
Prostaglandins (PGs) of the E series are recognized to play 
an important regulatory role in inflammation and immune 
responses [1,2]. PGE2 increases the expression of receptors 
on lymphocytes, promotes immunoglobulin synthesis, inhibits 
interleukin production, cytotoxicity and lymphocyte prolifer-
ation [1,3,4]. The broad range of PGE2 biological actions is 
mediated through its binding to specific plasma membrane 
receptors [5]. Based on the affinity to receptor-specific agonists 
and antagonists and on their association with different intra-
cellular signaling pathways, the PGE2 receptors are divided 
into subclasses [4,6,7]. Thus PGE2 can modulate cell responses 
through multiple pathways. 
While lymphocytes themselves do not synthesize PGE2, 
non-lymphoid inhabitants of the lymphocyte microenviron-
ment such as macrophages, follicular dendritic cells, fibro-
blasts, and vascular endothelial cells produce PGE2. This pro-
duction dramatically increases in response to a variety of 
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immunological and inflammatory stimuli (mitogens, cyto-
kines, or tumor promoters) [3], and so much attention is 
paid to the analysis of PGE2 effects under these conditions. 
Meanwhile, it is known that the key enzyme of PG synthesis, 
prostaglandin H synthase (PGHS) [8], exists in two isoforms, 
PGHS-1 and -2. PGHS-1 is usually described on non-stimu-
lated cells and referred to as the 'constitutive' form of PGHS. 
Accordingly, PGHS-2 is referred to as the 'inducible' form of 
PGHS, as it is not expressed in most cells and tissues and it 
can be induced in cells treated with inflammatory stimuli [9]. 
The existence of a constitutive form of PGHS indicates that 
the level of PG synthesis by non-stimulated cells (basal level) 
may be important in a long-term regulation process. Previ-
ously we have shown that the basal level of arachidonic 
acid (AA) metabolites on non-stimulated peritoneal macro-
phages is modulated by opioid substances like morphine [10] 
or by an inhibitor of PGHS, ibuprofen [11]. There was also an 
observation that basal PG synthesis depended upon the time 
of macrophage cultivation [12]. Despite these data it is still 
unknown what role, if any, prostanoid synthesis by non-
stimulated macrophages plays in the cellular immune re-
sponse. In order to find out any correlation between basal 
prostanoid synthesis by macrophages and mitogen-stimulated 
lymphocyte proliferation we investigated the mouse spleno-
cyte proliferation system and showed that both increase and 
decrease of the basal PGE2 level leads to the suppression of 
lymphocyte proliferation, whereas at PGE2 concentrations 
corresponding to the basal PGE2 level the lymphocyte prolif-
eration was not changed. 
2. Materials and methods 
2.1. Cell cultures 
Macrophages and splenocytes were obtained from 5-6 week old 
CBA male mice. The mice were killed by cervical dislocation. The 
macrophages were collected from five or six untreated mice by peri-
toneal lavage with Dulbecco's modified Eagle's medium (DMEM, 
Sigma), supplemented with 2 mM L-glutamine (Sigma), sodium bicar-
bonate and penicillin-streptomycin (2% solution). After several washes 
the cells (1.2-1.8 X 106/ml) were plated out on culture dishes and in-
cubated for 2-3 h with 10% heat-inactivated fetal calf serum (FCS, 
Flow) at 37°C in a humidified atmosphere of 95% air and 5% CO2 to 
allow adherence. Then non-adherent cells were removed and fresh 
medium was added to the macrophage monolayers. For splenocyte 
preparation a spleen was put into PBS, minced, centrifuged at 300 Xg 
for 10 min and resuspended in complete RPMI 1640 medium (Serva) 
supplemented with 10% heat-inactivated FCS, 2 mM L-glutamine, 100 
mM HEPES, sodium bicarbonate and penicillin-streptomycin (2% 
solution). Cell viability was estimated by the trypan blue test and 
was never below 96%. 
2.2. Turnover of [''Hj'arachidonic acid in macrophages 
Adherent macrophages in 96-well plates were cultured in fresh 
DMEM supplemented with 2% FCS and with the addition of 25 
nCi of [3H]AA (186 Ci/mmol). After 4 h the macrophages were 
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washed three times with phosphate-buffered saline (PBS) with 0.5% 
bovine serum albumin (BSA, Serva). Then the cells were incubated in 
fresh DMEM with 0.5% BSA for different time intervals. The radio-
activity of supernatants was determined by standard liquid scintilla-
tion counting. 
2.3. High-pressure liquid chromatography of prostanoids 
Adherent macrophages in 24-well plates were cultured in fresh 
DMEM supplemented with 0.5% BSA. Splenocytes in 6-well plates 
were cultured in complete RPMI 1640 (4X 106/ml) and at the chosen 
time cell supernatants were collected and gently centrifuged. Prosta-
noids synthesized by the cells were determined as derivatives of 4-
bromomethyl-7-methoxycoumarin (BrMMC, Sigma) by HPLC with 
fluorescent detection as described previously [13]. Briefly, cell super-
natants were acidified with 1 M HC1 to pH 3.0 prior to extraction 
with ethyl acetate. The extracts were left overnight with sodium sul-
fate. The solvent was evaporated to dryness under a stream of nitro-
gen. The residues were dissolved in acetonitrile and stored at —20°C. 
The BrMMC (4 mM, 50 ul in acetonitrile) and potassium carbonate 
(1 mg) were added to the samples, vortexed and kept at 50°C for 15 
min in the darkness. The samples were applied to a reverse-phase 
HPLC column C w ('Diasorb'-130 T, 6 (xm, 250X4 mm) and eluted 
with acetonitrile-water (1:1, v/v), the flow rate was 0.8 ml/min. The 
excitation wavelength was set at 313 nm, the emission wavelength at 
370 nm. For calibration authentic standards were used. Retention 
times were 11,17 and 29 min for PGE2, PGF2a and TxB2 respectively. 
The detection limit was in the range of 0.1-3.0 ng depending on the 
prostanoid type. 
2.4. Mitogen-induced proliferation 
Splenocytes in 96-well plates were cultured in complete RPMI 1640 
(initial cell concentration 106/ml) for different time periods. The final 
concentration of concanavalin A (Con A, Fluka) was 2 ug/ml. The 
effects of the concentration of PGE2 on cell proliferation were inves-
tigated in 12 independent experiments. For these experiments PGE2 
and Con A were added to the cells simultaneously. The effect of PGE2 
depending on the time of its addition was studied in three independent 
experiments. PGE2 at 10~
8 M and 10~12 M was added 1 h before 
initiating the proliferation and also simultaneously with mitogen ad-
dition. During the last 24 h the cells were pulsed with [3H]thymidine 
(25 Ci/mmol, final concentration 5 uCi/ml). Then the cells were har-
vested on paper filters and the amount of [3H]thymidine incorporated 
into the cells was measured by standard liquid scintillation counting. 
The results shown are the means of triplicate determinsations which 
varied by less than 7%. 
3. Results and discussion 
3.1. PG synthesis by non-stimulated peritoneal and spleen 
macrophages 
We examined the ability of non-stimulated peritoneal mac-
rophages to synthesize prostanoids during cell cultivation. The 
cells were prelabeled with [3H]AA, and the kinetics of radio-
active product release during the macrophage cultivation was 
studied. The extracellular release of labeled [3H]AA and its 
metabolites began 1 h after the addition of fresh medium, 
reached a constant level in 4 h and then remained constant 
for 12 h at least (Fig. 1). Based on these results we selected the 
time points for H P L C detection of PGs . It was determined 
that during cultivation macrophages synthesize prostanoids, 
Table 1 
Spontaneous prostanoid release by peritoneal macrophages 
1200 
1000 
Incubation time (h) 
1 
2 
4 
6 
Prostanoid synthesis (ng/10 
PGE2 
nd" 
33 ±13 
98 ±12 
85 ±10 
PGF2a 
nd 
31 ±7 
89 ±20 
80± 13 
' cells) 
TxB2 
nd 
16±2 
24 ±10 
nd 
and, not detectable. 
Time, h 
Fig. 1. Time course of [3H]AA metabolite release from mouse peri-
toneal macrophages. Cells were preincubated at 37°C with [3H]AA 
for 4 h; excess label was washed off and the cells were incubated at 
37°C in DMEM medium with 0.5% BSA. The [3H]AA metabolite 
content was measured as described in Section 2. Data are presented 
as the difference (A) between the radioactivity in the medium at any 
time point and the radioactivity at the beginning of the experiment. 
The results shown are the means of three independent experiments, 
which varied by less than 7%. 
especially PGE2, PGF2 a and TxB2. The basal prostanoid syn-
thesis was detectable 1 h after medium change, another 3 h 
later the prostanoid concentrations in the medium were set at 
a constant level (Table 1). So, non-stimulated peritoneal mac-
rophages are able not only to synthesize prostanoids but also 
to provide for their constant basal concentration in extracel-
lular medium. 
Immune responses are usually the result of close coopera-
tion between lymphocytes and macrophages. To examine the 
possibility of physiological significance of basal prostanoid 
synthesis by macrophages in the cellular immune response 
we selected a cell system from the mouse spleen as it contains 
both macrophages and lymphocytes. Lymphocytes are known 
not to synthesize prostanoids but to contain receptors for 
them [6,7], while macrophages are an important source of 
PGs. We determined prostanoid synthesis by splenocytes dur-
ing cultivation and found that non-stimulated cells are able to 
synthesize prostanoids, particularly PGF2 a and PGE2, and 
their concentrations in the medium reach a nanomolar basal 
level ( 3 . 3 ± 0 . 5 x l ( T 9 M and 3 . 0 ± 0 . 3 x l ( T 9 M, respectively) 
in a few hours. P G E 2 is an effective inhibitor of cell prolifer-
ation at 1 0 " 8 - 1 0 " 7 M [14,15], whereas P G F 2 a has very little 
immunomodulatory effect [14,16]. Thus, we further examined 
only the PGE2 effect on proliferation. 
3.2. PGE2 influence on the Con A-induced proliferation of 
splenocytes 
The influence of exogenous P G E 2 on the kinetics of Con A-
induced proliferation of spleen lymphocytes was studied. It 
was previously shown that at early incubation times endoge-
nous PGE2 had not been synthesized. For that reason PGE2 
was added to splenocytes as soon as possible after cell prep-
aration, so its concentrations remained unchanged in the be-
ginning of the experiments. The mitogen and P G E 2 were 
added simultaneously. The concentrations of 1 0 - 1 4 - 1 0 - 7 M 
of added PGE2 were both lower and higher than the basal 
level (1(T9 M) . 
We found that added P G E 2 did not change lymphocyte 
proliferation if its concentration was equal to the basal 
P G E 2 concentration in the splenocyte cell system (Fig. 2). 
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Time, h 
Fig. 2. Time courses of Con A-induced splenocyte proliferation 
under the influence of different PGE2 concentrations: 10~7 M (□), 
10"8 M (O), 10"9 M (0), 10"11 M ( A ) , 10"12 M (v) and 0 (•, 
control). The [3H]thymidine incorporation was measured as de-
scribed in Section 2. Con A (2 ag/ml, final concentration) and 
PGE2 were added simultaneously. The results presented here are 
representative of several separate experiments. 
Fig. 2 also shows that 10~7 M PGE2 inhibited the response 
during the whole time period of lymphocytes proliferation. 
Surprisingly, PGE2 at picomolar concentrations possessed 
the same potent inhibitory activity. The dynamics of the pro-
liferation response was slightly different in different experi-
ments, but the dose-response curves for 48 h and 72 h were 
the same (Fig. 3). Therefore, at PGE2 concentrations differing 
from the basal level (10 -9 M), both lower and higher, lym-
phocyte proliferation was suppressed in the same manner. 
log |PGE21 M] 
Fig. 3. Dose-response curves for PGE2 influence on Con A-induced 
splenocyte proliferation. The proliferation was measured by 
[3H]thymidine uptake by splenocytes after 48 h (A) or 72 h (B) of 
incubation. Con A (2 |xg/ml, final concentration) and PGE2 were 
added simultaneously. Control represents splenocyte Con A-induced 
proliferation without PGE2 addition. 
3.3. The effect ofPGE2 on lymphocyte proliferation depends on 
the time of addition 
To demonstrate a direct correlation between the change in 
the endogenous prostanoid levels and immune cell prolifera-
tive activity we examined this phenomenon as a function of 
the time of PGE2 addition. In these experiments PGE2 was 
added 1 h before mitogen addition or simultaneously with it. 
The incubation of the cells with PGE2 prior to mitogen addi-
tion led to a considerable increase of the suppressive effect of 
both high (10~8 M) and low (10~12 M) concentrations of 
PGE2 (Table 2). Our results provide evidence that any change 
in the basal amount of PGE2 formed by macrophages may be 
crucial in the modulation of the cellular immune response. 
Table 2 
Proliferative lymphocyte index as a function of the time of addition 
of PGE2 
PGE, 
0 
10"s 
10-12 
(M) Time of PGE2 
addition (h)a 
- 1 0 
— — 
— + 
+ — 
— + 
+ — 
Proliferative indexb 
cpmXKT3 
65±4 
36±2 
22±3 
58 ±3 
20±5 
% 
100 ±6 
55±3 
34±5 
89±5 
31 ±8 
aPGE2 was added 1 h before mitogen addition (—1) or simultaneously 
(0). 
bCells were incubated with 2 |ig/ml Con A for 72 h, [3H]thymidine 
was added 24 h before the cells were harvested. 
Besides, these experiments support the hypothesis that PGE2 
influences the early stages of mitogen action [17]. 
3.4. Conclusions 
The results obtained allow us to assume that the macro-
phage-lymphocyte immune cell system under physiological 
conditions is 'adapted' to the basal PGE2 concentration. Gen-
erally, an adaptation mechanism explains the effect of exoge-
nous concentrations of a substance in the presence of endog-
enous concentrations of it. The appropriate model of 
adaptation is based on the existence of receptors, which 
when activated conduct fast and slow signals with opposite 
contributions to the resulting effects [18]. In this case, a 
change in substance concentration in any direction will cause 
changes in the system. Such conditions can be reached in the 
PGE2 receptor system [6,7,19]. Thus it can be supposed that 
the level of PGE2 produced by non-stimulated macrophages 
has a regulatory role in lymphocyte proliferation. It means 
that an increase or decrease of the endogenous level of 
PGE2 during chronic diseases is capable of changing immune 
responses. The adaptation of lymphocyte proliferation to the 
physiological concentration of PGE2 (10~
9 M) may be impor-
tant to clarify the regulation of some immune functions. The 
increase of prostaglandin synthesis above the normal level is 
being intensively studied, but the reverse process is neglected. 
Our results demonstrate that not only the increase but also 
the decrease of basal PGE2 concentration, up to the picomo-
lar range, in pathophysiological conditions has regulatory im-
portance for lymphocyte proliferation. 
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